InsiderTrades

Form 4 for MGNX MACROGENICS INC

Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001125345-23-000041 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-24 2023-02-22 MGNX Peters Jeffrey Stuart GC, Senior VP F - Tax $6.55 -3,378 5,372 -39% -$22.1K
D 2023-02-24 2023-02-22 MGNX Peters Jeffrey Stuart GC, Senior VP M - OptEx $0.00 +8,750 8,750 New $0
D 2023-02-24 2023-02-22 MGNX Peters Jeffrey Stuart GC, Senior VP M - OptEx $0.00 -8,750 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-22 F D 3,378 $6.55 5,372 D — —
2 Common Common Stock 2023-02-22 M A 8,750 $0.00 8,750 D — — (F1) On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.
3 Derivative Restricted Stock Unit 2023-02-22 M D 8,750 $0.00 0 D $0.00 · — to — 8,750 Common Stock (F1) On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.